Si XB, Zhang XM, Lan Y. Berberine-based quadruple therapy for patients with
Helicobacter pylori associated peptic ulcer: A meta-analysis.
Shijie Huaren Xiaohua Zazhi 2018;
26:1864-1873. [DOI:
10.11569/wcjd.v26.i32.1864]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM
To compare the efficacy and safety of berberine-based quadruple therapy and classical triple therapy (a proton pump inhibitor with two antibiotics) in patients with Helicobacter pylori (H. pylori) associated peptic ulcer.
METHODS
Electronic databases including Medline, EMBASE, Web of Science, Cochrane Central Register of Controlled Trial, Wanfang Database, and VIP Database were searched with the search terms of "berberine AND H. pylori AND eradication". A funnel plot was adopted to evaluate publication bias. The meta-analysis was performed using a fixed effects model in case of low heterogeneity and a randomized effects model in case of high heterogeneity.
RESULTS
A total of seven randomized controlled trials (RCTs) with 948 subjects were included. The eradication rate (86.78% vs 70.04%), healing rate of ulcer (50.73% vs 40.30%), and total effective rate (94.57% vs 81.66%) in the berberine group were significantly higher than those in the control group. In addition, the total incidence of side effects in the berberine group was significantly lower than that of the control group (26.54% vs 40.44%).
CONCLUSION
Compared with proton pump inhibitor-based triple therapy, berberine-based quadruple therapy might improve eradication rate and promote the healing of gastric ulcer in patients with H. pylori associated peptic ulcer. In addition, berberine-based quadruple therapy might reduce the side effects throughout the therapy. More RCTs with high quality are expected to confirm our finding.
Collapse